2-{[(1S)-1-methylbutyl]oxy}-8-(methyloxy)-1H-purin-6-amine | 1050497-20-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 2-{[(1S)-1-methylbutyl]oxy}-8-(methyloxy)-1H-purin-6-amine
• 英文别名: 8-methoxy-2-[(2S)-pentan-2-yl]oxy-7H-purin-6-amine
• CAS: 1050497-20-5
• 化学式: C₁₁H₁₇N₅O₂
• 分子量: 251.288
• InChiKey: XQSCBILAOAZJPM-LURJTMIESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  98.9
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-{[(1S)-1-methylbutyl]oxy}-8-(methyloxy)-1H-purin-6-amine 在 盐酸 、 potassium carbonate 作用下， 以 1,4-二氧六环 、 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 2.0h， 生成 6-amino-2-[(1S)-1-methylbutoxy]-9-(4-piperidinylmethyl)-7,9-dihydro-8H-purin-8-one hydrochloride
  参考文献：
  名称：

  Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity

  摘要：

  Toll-like receptors 7 and 8 (TLR7/8) agonists are potent immunostimulants that are attracting considerable interest as vaccine adjuvants. We recently reported the synthesis of a new series of 2-O-butyl-8-oxoadenines substituted at the 9-position with various linkers and N-heterocycles, and showed that TLR7/8 selectivity, potency and cytokine induction could be modulated by varying the alkyl linker length and the N-heterocyclic ring. In the present study, we further optimized the oxoadenine scaffold by investigating the effect of different substituents at the 2-position of the oxoadenine on TLR7/8 potency/selectivity, cytokine induction and DC maturation in human PBMCs. The results show that introducing a 1-(S)-methylbutoxy group at the 2-position of the oxoadenine significantly increased potency for TLR7/8 activity, cytokine induction and DC maturation.

  DOI：

  10.1016/j.bmcl.2020.126984
• 作为产物：
  描述：

  (S)-(+)-2-戊醇 在 N-溴代丁二酰亚胺(NBS) 、 三氟乙酸 、 sodium t-butanolate 作用下， 以 甲醇 为溶剂， 反应 73.0h， 生成 2-{[(1S)-1-methylbutyl]oxy}-8-(methyloxy)-1H-purin-6-amine
  参考文献：
  名称：

  Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity

  摘要：

  Toll-like receptors 7 and 8 (TLR7/8) agonists are potent immunostimulants that are attracting considerable interest as vaccine adjuvants. We recently reported the synthesis of a new series of 2-O-butyl-8-oxoadenines substituted at the 9-position with various linkers and N-heterocycles, and showed that TLR7/8 selectivity, potency and cytokine induction could be modulated by varying the alkyl linker length and the N-heterocyclic ring. In the present study, we further optimized the oxoadenine scaffold by investigating the effect of different substituents at the 2-position of the oxoadenine on TLR7/8 potency/selectivity, cytokine induction and DC maturation in human PBMCs. The results show that introducing a 1-(S)-methylbutoxy group at the 2-position of the oxoadenine significantly increased potency for TLR7/8 activity, cytokine induction and DC maturation.

  DOI：

  10.1016/j.bmcl.2020.126984

文献信息

• [EN] ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS<br/>[FR] DÉRIVÉS D'ADÉNINE UTILES POUR TRAITER DES MALADIES ALLERGIQUES OU D'AUTRES PATHOLOGIES INFLAMMATOIRES
  申请人：GLAXOSMITHKLINE BIOLOG SA

  公开号：WO2016075661A1

  公开（公告）日：2016-05-19

  Compounds of formula (I).

  化合物的化学式（I）。
• [EN] NOVEL ADENINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS D'ADÉNINE
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2010018134A1

  公开（公告）日：2010-02-18

  Compounds of formula (I) wherein R1 is C1-6alkylamino, or C1-6alkoxy; R2 is a group having the structure (II): n is an integer having a value of 1 to 6; Het is a 6-membered saturated heterocycle containing one nitrogen atom wherein Het is attached to the -(CH2)n- moiety at any carbon atom of the heterocycle; R3 is hydrogen, C1-8alkyl, or C3-7cycloalkylC0-6alkyl; and salts thereof are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, the treatment of infectious diseases and cancer, and may also be useful as vaccine adjuvants.

  式(I)的化合物中，其中R1是C1-6烷基氨基或C1-6烷氧基；R2是具有结构(II)的基团：n是一个值为1至6的整数；Het是一个含有一个氮原子的6元饱和杂环，其中Het连接到杂环的任何碳原子上的-(CH2)n-基团；R3是氢、C1-8烷基或C3-7环烷基C0-6烷基；以及其盐是人干扰素的诱导剂。诱导人干扰素的化合物可能在治疗各种疾病中有用，例如治疗过敏性疾病和其他炎症性疾病，例如过敏性鼻炎和哮喘，治疗传染性疾病和癌症，并且还可能作为疫苗佐剂有用。
• [EN] PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES<br/>[FR] DÉRIVÉS DE PURINE DESTINÉS À ÊTRE UTILISÉS POUR LE TRAITEMENT DE MALADIES ALLERGIQUES, INFLAMMATOIRES ET INFECTIEUSES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2010018130A1

  公开（公告）日：2010-02-18

  Compounds of formula (I): wherein R1 is C1-6alkylamino, or C1-6alkoxy; m is an integer having a value of 3, 4, or 5; n is an integer having a value of 0 to 3; p is an integer having a value of 1 or 2 and salts thereof are inducers of human interferon. Compounds which induce human interferon may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, the treatment of infectious diseases and cancer, and may also be useful as vaccine adjuvants.

  式（I）的化合物：其中R1为C1-6烷基氨基或C1-6烷氧基；m为3、4或5的整数；n为0至3的整数；p为1或2的整数及其盐是人类干扰素的诱导剂。诱导人类干扰素的化合物可能在治疗各种疾病方面有用，例如治疗过敏性疾病和其他炎症性疾病，例如过敏性鼻炎和哮喘，治疗传染病和癌症，也可能作为疫苗佐剂有用。
• [EN] COMPOSITIONS AND USES<br/>[FR] COMPOSITIONS ET LEURS UTILISATIONS
  申请人：GLAXOSMITHKLINE BIOLOGICALS SA

  公开号：WO2016142880A1

  公开（公告）日：2016-09-15

  The present invention relates to immunogenic compositions and methods for producing them, and in particular, immunogenic compositions comprising a protein antigen cross linked to an oxoadenine adjuvant.

  本发明涉及免疫原组合物及其制备方法，特别是包含蛋白质抗原与氧化腺嘌呤佐剂交联的免疫原组合物。
• [EN] 6-AMINO-2-{ [ (1S)-1-METHYLBUTYL] OXY}-9-[5-(1-PIPERIDINYL)-7,9-DIHYDRO-8H-PURIN-8-ONE MALEATE<br/>[FR] MALÉATE DE 6-AMINO-2-{[(1S)-1-MÉTHYLBUTYLE]OXY}-9-[5-(1-PIPÉRIDINYLE)-7,9 -DIHYDRO-8H-PURIN-ONE
  申请人：GLAXOSMITHKLINE LLC

  公开号：WO2011098452A1

  公开（公告）日：2011-08-18

  A compound which is 6-amino-2-[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one: Formula (I) in the form of a maleate salt, may be useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions for example allergic rhinitis and asthma, the treatment of infectious diseases and cancer, and may also be useful as vaccine adjuvants.

  一种化合物，即6-氨基-2-[(1S)-1-甲基丁基]氧基}-9-[5-(1-哌啶基)戊基]-7,9-二氢-8H-嘌呤-8-酮：化学式(I)以马来酸盐的形式，可能对治疗各种疾病有用，例如治疗过敏性疾病和其他炎症性疾病，例如过敏性鼻炎和哮喘，治疗传染病和癌症，并且可能也有用作疫苗佐剂。